Literature DB >> 25549931

Predictors of respiratory-induced lung tumour motion measured on four-dimensional computed tomography.

K V Tan1, R Thomas2, N Hardcastle3, D Pham2, T Kron4, F Foroudi5, D Ball5, L Te Marvelde6, M Bressel6, S Siva5.   

Abstract

AIMS: The delivery of radical radiotherapy in lung cancer is complicated by respiratory-induced tumour motion. The aim of the study was to correlate tumour motion characteristics with tumour and patient factors, particularly the anatomical lobe and pulmonary zone.
MATERIALS AND METHODS: Lung tumour volumes on four-dimensional computed tomography were delineated by a single observer at maximal expiration and propagated through all 10 phases of the breathing cycle. Movements were tracked in the superior-inferior (SI), anterior-posterior (AP) and medio-lateral (ML) directions by changes in the tumour centroid coordinates. Tumour motion characteristics were correlated with anatomical lobe, pulmonary zone, tumour volume, T-stage, smoking status and spirometry.
RESULTS: In 101 consecutive patients, the median magnitude of tumour motion in the SI direction was significantly larger in tumours located in lower lobes compared with upper lobes and middle/lingular lobes (0.70 cm versus 0.09 cm versus 0.26 cm, P < 0.01). No significant difference was found in median tumour motion between lower, upper and middle/lingular lobes in the AP (0.16 cm versus 0.13 cm versus 0.16 cm, P = 0.45) and ML (0.08 cm versus 0.08 cm versus 0.13 cm, P = 0.32) directions, respectively. When assessed by zone, the median tumour displacement in the SI direction was significantly larger in the lower zones (0.81 cm) as compared with the middle zones (0.30 cm) and upper zones (0.11 cm), P < 0.01. No difference was observed in the AP (P = 0.45) and ML (P = 0.73) directions. Tumour volume, T-stage and forced expiratory ratio were not statistically significant predictors of respiratory-induced tumour motion.
CONCLUSION: Respiratory-induced tumour motion in the SI direction was significantly greater in lower lobe and lower pulmonary zone tumours compared with apical tumours. Tumour volume, T-stage and spirometry did not correlate with the magnitude or direction of respiratory-induced tumour motion. During curative radiotherapy in lung cancer, attention should be paid to motion management, especially for lower lobe tumours.
Copyright © 2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Four-dimensional computed tomography; motion; respiratory induced

Mesh:

Year:  2014        PMID: 25549931     DOI: 10.1016/j.clon.2014.12.001

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  4 in total

1.  Automated identification and reduction of artifacts in cine four-dimensional computed tomography (4DCT) images using respiratory motion model.

Authors:  Min Li; Sarah Joy Castillo; Richard Castillo; Edward Castillo; Thomas Guerrero; Liang Xiao; Xiaolin Zheng
Journal:  Int J Comput Assist Radiol Surg       Date:  2017-02-14       Impact factor: 2.924

2.  Quantification of interplay and gradient effects for lung stereotactic ablative radiotherapy (SABR) treatments.

Authors:  Madelaine K Tyler
Journal:  J Appl Clin Med Phys       Date:  2016-01-08       Impact factor: 2.102

3.  Evaluation of lung tumor motion in a large sample: Target-related and clinical factors influencing tumor motion based on four-dimensional CT.

Authors:  Fengxiang Li; Yanlin Qu; Tingting Zhang; Zhen Cui; Xin Sun; Tao Zhang; Jianbin Li
Journal:  Cancer Med       Date:  2021-09-14       Impact factor: 4.452

4.  Erring Characteristics of Deformable Image Registration-Based Auto-Propagation for Internal Target Volume in Radiotherapy of Locally Advanced Non-Small Cell Lung Cancer.

Authors:  Benjamin J Rich; Benjamin O Spieler; Yidong Yang; Lori Young; William Amestoy; Maria Monterroso; Lora Wang; Alan Dal Pra; Fei Yang
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.